BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling
{{output}}
Erythropoiesis is a crucial process in hematopoiesis, yet it remains highly susceptible to disruption by various diseases, which significantly contribute to the global challenges of anemia and blood shortages. Current treatments like erythropoietin (EPO) or gl... ...